# Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC

> **NCT05873439** · EARLY_PHASE1 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 3 (actual)

## Conditions studied

- Nonsmall Cell Lung Cancer
- Nonsmall Cell Lung Cancer, Stage II
- Nonsmall Cell Lung Cancer Stage III
- Unresectable Non-Small Cell Lung Carcinoma

## Interventions

- **RADIATION:** Genomically Guided Radiation Therapy (RT)

## Key facts

- **NCT ID:** NCT05873439
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-25
- **Primary completion:** 2023-11-29
- **Final completion:** 2024-08-21
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05873439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05873439, "Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT05873439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*